Human parainfluenza virus 3 neuraminidase activity contributes to dendritic cell maturation

Viral Immunology

Volumn 18, Issue 3, 2005, Pages 523-533

  Horga, Maria Arantxa ^a   Macip, Salvador ^a   Tuyama, Ana C ^a   Tan, Maria C ^a   Gusella, G Luca ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; HN PROTEIN; LYMPHOCYTE SURFACE MARKER; SIALIDASE; CHEMOKINE;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; PARAINFLUENZA VIRUS 3; VIRUS INFECTION; VIRUS REPLICATION; BIOSYNTHESIS; CELL DIFFERENTIATION; CLOSTRIDIUM PERFRINGENS; ENZYMOLOGY; GENETICS; IMMUNOLOGY; IN VITRO STUDY; MUTATION; PATHOGENICITY; PATHOLOGY; RNA VIRUS INFECTION; SPECIES DIFFERENCE; VIRUS GENE;

HUMAN PARAINFLUENZA VIRUS 3;

CELL DIFFERENTIATION; CHEMOKINES; CLOSTRIDIUM PERFRINGENS; CYTOKINES; DENDRITIC CELLS; GENES, VIRAL; HUMANS; MUTATION; NEURAMINIDASE; PARAINFLUENZA VIRUS 3, HUMAN; RESPIROVIRUS INFECTIONS; SPECIES SPECIFICITY;

EID: 32944475818     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.523     Document Type: Article

References (55)

1. Ah-Tye, C., S. Schwartz, K. Huberman, et al. 1999. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3. Microb. Pathog. 27:329-336.
2. Andrews, D.M., C.E. Andoniou, F. Granucci, et al. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:1077-1084.
3. Bender, A., M. Albert, A. Reddy, et al. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology 198:552-567.
4. Bieback, K., E. Lien, I.M. Klagge, et al. 2002. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76:8729-8736.
5. Cella, M., M. Salio, Y. Sakakibara, et al. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821-829.
6. Collins, P.L., and B.R. Murphy. 2002. Respiratory syncytial virus: reverse genetics and vaccine strategies. Virology 296:204-211.
7. Garofalo, R., A. Dorris, S. Ahlstedt, et al. 1994. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease. Pediatr. Allergy Immunol. 5:111-117.
8. Glezen, P., and F.W. Denny. 1973. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288:498-505.
9. Graham, B.S., J.A. Rutigliano, and T.R. Johnson. 2002. Respiratory syncytial virus immunobiology and pathogenesis. Virology 297:1-7.
10. Hall, C.B. 2001. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:1917-1928.
11. Haller, A.A., T. Miller, M. Mitiku, et al. 2000. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J. Virol. 74:11626-11635.
12. Horga, M.A., G.L. Gusella, O. Greengard, et al. 2000. Mechanism of interference mediated by human parainfluenza virus type 3 infection. J. Virol. 74:11792-11799.
13. Horvath, C.M., R.G. Paterson, M.A. Shaughnessy, et al. 1992. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J. Virol. 66:4564-4569.
14. Huberman, K., R.W. Peluso, and A. Moscona. 1995. Hemagglutinin- neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle. Virology 214:294-300.
15. Jacobson, N.G., S.J. Szabo, R.M. Weber-Nordt, et al. 1995. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755-1762.
16. Johnson, T.R., and B.S. Graham. 1999. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J. Virol. 73:8485-8495.
17. Johnson, T.R., J.E. Johnson, S.R. Roberts, et al. 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72:2871-2880.
18. Karron, R.A., M. Makhene, K. Gay, et al. 1996. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr. Infect. Dis. J. 15:650-654.
19. Karron, R.A., P.F. Wright, S.L. Hall, et al. 1995. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J. Infect. Dis. 171:1107-1114.
20. Karron, R.A., P.F. Wright, F.K. Newman, et al. 1995. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 172:1445-1450.
21. Klagge, I.M., and S. Schneider-Schaulies. 1999. Virus interactions with dendritic cells. J. Gen. Virol. 80:823-833.
22. Klagge, I.M., V. ter Meulen, and S. Schneider-Schaulies. 2000. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface. Eur. J. Immunol. 30:2741-2750.
23. Kopp, E., and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396-401.
24. Lamb, R.A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
25. Larsson, M., A.S. Beignon, and N. Bhardwaj. 2004. DC-virus interplay: a double edged sword. Semin. Immunol. 16:147-161.
26. Levin Perlman, S., M. Jordan, R. Brossmer, et al. 1999. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3. Virology 265:57-65.
27. Lichtman, M.A., and R.I. Weed. 1972. Alteration of the cell periphery during granulocyte maturation: relationship to cell function. Blood 39:301-316.
28. Lund-Johansen, F., and L.W. Terstappen. 1993. Differential surface expression of cell adhesion molecules during granulocyte maturation. J. Leukoc. Biol. 54:47-55.
29. Moscona, A., and R.W. Peluso. 1991. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J. Virol. 65:2773-2777.
30. Moscona, A., and R.W. Peluso. 1992. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J. Virol. 66:6280-6287.
31. Moscona, A., and R.W. Peluso. 1993. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J. Virol. 67:6463-6468.
32. Oh, S., and M.C. Eichelberger. 1999. Influenza virus neuraminidase alters allogeneic T cell proliferation. Virology 264:427-435.
33. Olszewska-Pazdrak, B., A. Casola, T. Saito, et al. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1 alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72:4756-4764.
34. Olszewska-Pazdrak, B., K. Pazdrak, P.L. Ogra, et al. 1998. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism. J. Immunol. 160:4889-4895.
35. Openshaw, P.J., S.L. Clarke, and P.M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493-500.
36. Openshaw, P.J., and G. Walzl. 1999. Infections prevent the development of asthma-true, false or both? J. R. Soc. Med. 92:495-499.
37. Parronchi, P., M. De Carli, R. Manetti, et al. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977-2983.
38. Plotnicky-Gilquin, H., D. Cyblat, J.P. Aubry, et al. 2001. Differential effects of parainfluenza virus type 3 on human monocytes and dendritic cells. Virology 285:82-90.
39. Polack, F.P., P.G. Auwaerter, S.H. Lee, et al. 1999. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat. Med. 5:629-634.
40. Porotto, M., O. Greengard, N. Poltoratskaia, et al. 2001. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant. J. Virol. 75:7481-7488.
41. Porotto, M., M. Murrell, O. Greengard, et al. 2005. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J. Virol. 79:2383-2392.
42. Prince, G.A., M.G. Ottolini and A. Moscona. 2001. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo. J. Virol. 75:12446-12451.
43. Prince, G.A., J.P. Prieels, M. Slaoui, et al. 1999. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab. Invest. 79:1385-1392.
44. Reed, G., P.H. Jewett, J. Thompson, et al. 1997. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J. Infect. Dis. 175:807-813.
45. Rogge, L., L. Barberis-Maino, M. Biffi, et al. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
46. Sakarya, S., S. Rifat, J. Zhou, et al. 2004. Mobilization of neutrophil sialidase activity desialylates the pulmonary vascular endothelial surface and increases resting neutrophil adhesion to and migration across the endothelium. Glycobiology 14:481-494.
47. Salio, M., M. Cella, M. Suter, et al. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29:3245-3253.
48. Sanchez-Lanier, M., P. Guerin, L.C. McLaren, et al. 1988. Measles virus-induced suppression of lymphocyte proliferation. Cell Immunol. 116:367-381.
49. Schneider-Schaulies, S., K. Bieback, E. Avota, et al. 2002. Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation. J. Mol. Med. 80:73-85.
50. Schneider-Schaulies, S., S. Niewiesk, J. Schneider-Schaulies, et al. 2001. Measles virus induced immunosuppression: targets and effector mechanisms. Curr. Mol. Med. 1:163-181.
51. Schneider-Schaulies, S., B.K. Rima, and T. Hunig. 2002. Viral pathogenesis and immune control. J. Neurovirol. 8:464-469.
52. Sheeran, P., H. Jafri, C. Carubelli, et al. 1999. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 18:115-122.
53. Skiadopoulos, M.H., S.R. Surman, J.M. Riggs, et al. 2002. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expression up to three foreign glycoproteins. Virology 297:136-152.
54. Welliver, R.C. 2000. Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma. Pediatr. Infect. Dis. J. 19:780-783.
55. Yewdell, J.W., and A.B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3:1019-1025.